ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,408.90
0.36%
S&P ASX All Technology
3,893.00
0.20%
Brent Oil
77.155
-0.04%
US Dollar vs AUD
1.58861
0.32%
Bitcoin
101,308.88
-1.32%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Eli Lilly And Co (0Q1G)

  7. Eli Lilly And Co (0Q1G) News

0Q1G

Eli Lilly (0Q1G)

Eli Lilly And Co
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0Q1G
DateTimeSourceHeadlineSymbolCompany
15/01/202501:33Alliance NewsAlliance NewsEli Lilly shares fall as lowers fourth quarter revenue guidanceLSE:0Q1GEli Lilly And Co
16/12/202418:54Alliance NewsAlliance NewsLSE:0Q1GEli Lilly And Co
26/11/202417:42Alliance NewsAlliance NewsNovo Nordisk diabetes and obesity drugs also protect kidneys — studyLSE:0Q1GEli Lilly And Co
30/10/202423:24Alliance NewsAlliance NewsTOP NEWS: Eli Lilly returns to profit in quarter, downgrades guidanceLSE:0Q1GEli Lilly And Co
09/09/202421:16Alliance NewsAlliance NewsEli Lilly names Lucas Montarce as new chief financial officerLSE:0Q1GEli Lilly And Co
08/08/202421:57Alliance NewsAlliance NewsTOP NEWS: Eli Lilly lifts guidance as Mounjaro and Zepbound sales jumpLSE:0Q1GEli Lilly And Co
09/07/202404:58Alliance NewsAlliance NewsEli Lilly weight loss drug beats Ozempic in head-to-head studyLSE:0Q1GEli Lilly And Co
05/06/202423:00Alliance NewsAlliance NewsTOP NEWS: Alphabet poaches Eli Lilly CFO Anat Ashkenazi for same roleLSE:0Q1GEli Lilly And Co
21/05/202422:14Alliance NewsAlliance News*Eli Lilly: over half of Crohn's disease patients reach remission at 1 year w/ mirikzumabLSE:0Q1GEli Lilly And Co
16/05/202406:07Alliance NewsAlliance NewsEli Lilly reaches settlement with Totality MedispaLSE:0Q1GEli Lilly And Co
30/04/202422:26Alliance NewsAlliance NewsTOP NEWS: Eli Lilly lifts outlook, ramps up production to meet demandLSE:0Q1GEli Lilly And Co
09/03/202402:16Alliance NewsAlliance NewsEli Lilly's Donanemab Alzheimer's drug hit by delaysLSE:0Q1GEli Lilly And Co
06/02/202423:44Alliance NewsAlliance NewsTOP NEWS: Eli Lilly eyes beefier sales amid weight loss drug crazeLSE:0Q1GEli Lilly And Co
26/01/202417:04Alliance NewsAlliance NewsEli Lilly weight loss drug could be supplied to UK 'in weeks'LSE:0Q1GEli Lilly And Co
24/01/202405:48Alliance NewsAlliance NewsIN BRIEF: Eli Lilly hails upbeat trial data for hearing loss therapyLSE:0Q1GEli Lilly And Co
18/11/202301:18Alliance NewsAlliance NewsTOP NEWS: Eli Lilly to invest USD2.5 billion in GermanyLSE:0Q1GEli Lilly And Co
09/11/202317:09Alliance NewsAlliance NewsEli Lilly diabetes drug authorised for weight management, loss in UKLSE:0Q1GEli Lilly And Co
09/11/202307:15Alliance NewsAlliance NewsUS approves highly anticipated Eli Lilly weight loss drugLSE:0Q1GEli Lilly And Co
02/11/202322:42Alliance NewsAlliance NewsTOP NEWS: Eli Lilly cuts yearly outlook on chunky R&D costsLSE:0Q1GEli Lilly And Co
08/08/202321:23Alliance NewsAlliance NewsTOP NEWS: Eli Lilly second quarter profit up, notes pipeline successesLSE:0Q1GEli Lilly And Co
22/06/202304:34Alliance NewsAlliance NewsUS FDA approves Eli Lilly's Jardiance drug for diabetes in childrenLSE:0Q1GEli Lilly And Co
27/04/202322:28Alliance NewsAlliance NewsTOP NEWS: Eli Lilly quarterly revenue down on reduced Covid-19 demandLSE:0Q1GEli Lilly And Co
04/03/202308:20Alliance NewsAlliance NewsIN BRIEF: US FDA approves expanded indication for Eli Lilly's VerzenioLSE:0Q1GEli Lilly And Co
02/03/202300:42Alliance NewsAlliance NewsUS drugmaker Eli Lilly says slashing insulin prices by 70%LSE:0Q1GEli Lilly And Co
03/02/202307:17Alliance NewsAlliance NewsEli Lilly & Co sees quarterly revenue fall amid declining volumesLSE:0Q1GEli Lilly And Co
02/11/202203:24Alliance NewsAlliance NewsEli Lilly lowers full year guidance despite positive earnings figuresLSE:0Q1GEli Lilly And Co
04/08/202221:23Alliance NewsAlliance NewsTOP NEWS: Eli Lilly cuts annual guidance as second quarter disappointsLSE:0Q1GEli Lilly And Co
04/02/202202:17Alliance NewsAlliance NewsEli Lilly sees net income fall but outlook for 2022 remains unchangedLSE:0Q1GEli Lilly And Co
 Showing the most relevant articles for your search:LSE:0Q1G

Your Recent History

NYSE
MRK
Merck
ASX
NAB
National Australia Bank
ASX
MQG
Macquarie
ASX
RIO
Rio Tinto
ASX
TLS
Telstra
ASX
CSL
CSL
NASDAQ
TSLA
Tesla
ASX
BHP
BHP
ASX
XTO
S&P ASX 100
ASX
AMP
AMP
PM
XAUUSD
Gold vs US Dollar
NASDAQ
NVDA
NVIDIA
ASX
NCM
Newcrest Mining
ASX
WPL
Woodside Petroleum
ASX
WDC
Westfield
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads